ARTICLE | Clinical News
GRNOPC1: IND resumed
August 2, 2010 7:00 AM UTC
FDA lifted the clinical hold placed on an IND for a U.S. Phase I trial of GRNOPC1 to treat acute spinal cord injury. The trial for the human embryonic stem cell (hESC)-derived oligodendrocytes is expe...